Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients
- 1 March 1991
- journal article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 34 (2) , 123-127
- https://doi.org/10.1007/bf01741346
Abstract
Peripheral blood monocytes from non-Hodgkin's lymphoma (NHL) patients were assessed for the monocyte functions with respect to their ability to secrete interleukin-1 and tumour necrosis factor (TNF) and their cytotoxic potential to tumour target WEHI 164 clone 13. Our results indicate comparable levels of interleukin-1 and TNF production by NHL patients. The cytotoxic potential by monocytes was also not depressed in these patients. The data obtained suggest normal monocyte functions in NHL patients.Keywords
This publication has 30 references indexed in Scilit:
- Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patientsCancer Immunology, Immunotherapy, 1990
- Generation and characterization of lymphokine-activated killer cells from non-Hodgkin's lymphoma patientsImmunology Letters, 1990
- TUMOUR NECROSIS FACTOR IN B CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1989
- MONOCYTE TNF PRODUCTION IN GASTROINTESTINAL CANCERThe Lancet, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- CACHECTIN/TUMOUR-NECROSIS-FACTOR PRODUCTION BY CANCER PATIENTSThe Lancet, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphomaEuropean Journal of Cancer and Clinical Oncology, 1985